My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 259

    1.

    Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.

    Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL.

    Ann Intern Med. 1994 May 1;120(9):771-83. Review.PMID: 8147551 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Current prospects for the treatment of clinical sepsis.

    Suffredini AF.

    Crit Care Med. 1994 Jul;22(7):S12-8. Review.PMID: 8026188 [PubMed - indexed for MEDLINE]Related articles

    3.

    Preclinical review of anti-tumor necrosis factor monoclonal antibodies.

    Bodmer M, Fournel MA, Hinshaw LB.

    Crit Care Med. 1993 Oct;21(10 Suppl):S441-6. Review.PMID: 8403982 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.

    Calandra T, Baumgartner JD, Glauser MP.

    Prog Clin Biol Res. 1991;367:141-59. Review.PMID: 1924424 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endotoxin as a drug target.

    Opal SM, Glück T.

    Crit Care Med. 2003 Jan;31(1 Suppl):S57-64. Review.PMID: 12544978 [PubMed - indexed for MEDLINE]Related articles

    6.

    Anti-inflammatory therapies in sepsis and septic shock.

    Freeman BD, Natanson C.

    Expert Opin Investig Drugs. 2000 Jul;9(7):1651-63. Review.PMID: 11060768 [PubMed - indexed for MEDLINE]Related articles

    7.

    Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.

    Fink MP.

    Crit Care Med. 1993 Feb;21(2 Suppl):S32-9. Review.PMID: 8428494 [PubMed - indexed for MEDLINE]Related articles

    8.

    Tumor necrosis factor: an updated review of its biology.

    Tracey KJ, Cerami A.

    Crit Care Med. 1993 Oct;21(10 Suppl):S415-22. Review.PMID: 8403979 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.

    Giroir BP.

    Crit Care Med. 1993 May;21(5):780-9. Review.PMID: 8482101 [PubMed - indexed for MEDLINE]Related articles

    10.

    Role of tumor necrosis factor-alpha in disease states and inflammation.

    Strieter RM, Kunkel SL, Bone RC.

    Crit Care Med. 1993 Oct;21(10 Suppl):S447-63. Review.PMID: 8403983 [PubMed - indexed for MEDLINE]Related articles

    11.

    Emerging therapies for sepsis and septic shock.

    Oh HM.

    Ann Acad Med Singapore. 1998 Sep;27(5):738-43. Review.PMID: 9919353 [PubMed - indexed for MEDLINE]Related articles

    12.

    Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL.

    Intensive Care Med. 2008 Jan;34(1):17-60. Epub 2007 Dec 4. Erratum in: Intensive Care Med. 2008 Apr;34(4):783-5. PMID: 18058085 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Antiendotoxin therapies for septic shock.

    Corriveau CC, Danner RL.

    Infect Agents Dis. 1993 Feb;2(1):44-52. Review.PMID: 8162353 [PubMed - indexed for MEDLINE]Related articles

    14.

    A critical evaluation of new agents for the treatment of sepsis.

    Bone RC.

    JAMA. 1991 Sep 25;266(12):1686-91. Review.PMID: 1886193 [PubMed - indexed for MEDLINE]Related articles

    15.

    Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.

    Fisher CJ Jr, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RM, Panacek EA, Vincent JL, et al.

    Crit Care Med. 1993 Mar;21(3):318-27.PMID: 8440099 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pathogenic effects of endotoxin.

    Zivot JB, Hoffman WD.

    New Horiz. 1995 May;3(2):267-75. Review.PMID: 7583168 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.

    Iskit AB, Guc O.

    Acta Pharmacol Sin. 2003 Oct;24(10):953-7. Review.PMID: 14531935 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Endotoxin as a therapeutic target in septic shock.

    Corriveau CC, Danner RL.

    Infect Agents Dis. 1993 Feb;2(1):35-43. Review.PMID: 8162352 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.

    Minneci P, Deans K, Natanson C, Eichacker PQ.

    Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):1-9. Epub 2003 Jan 28. Review.PMID: 12582737 [PubMed - indexed for MEDLINE]Related articles

    20.

    The role of nitric oxide in sepsis--an overview.

    Kirkebøen KA, Strand OA.

    Acta Anaesthesiol Scand. 1999 Mar;43(3):275-88. Review.PMID: 10081533 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity